NovaBridge Biosciences Revenue From Contract With Customer Excluding Assessed Tax

Quick Answer

NovaBridge Biosciences reported Revenue From Contract With Customer Excluding Assessed Tax of $13.81 million for the year ending 2021.

  • NovaBridge Biosciences showed a decrease of -99.1% in Revenue From Contract With Customer Excluding Assessed Tax from 2020 to 2021.
  • This data is from NovaBridge Biosciences's annual report (Form 10-K), filed with the SEC on April 29, 2022.
  • XBRL data for this metric is available from 2017 to 2021 (5 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 5 years of available data (2017 to 2021), NovaBridge Biosciences's Revenue From Contract With Customer Excluding Assessed Tax has grown by 19.5%.
  • Historical annual values: Fiscal year 2021: $13.81 million | Fiscal year 2020: $1.54 billion | Fiscal year 2019: $30.00 million | Fiscal year 2018: $53.78 million | Fiscal year 2017: $11.56 million.
  • Data sourced from SEC EDGAR public filings as of June 24, 2026.

Last verified: